S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What’s At Stake In April is Shocking (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
What’s At Stake In April is Shocking (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
What’s At Stake In April is Shocking (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What’s At Stake In April is Shocking (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
What’s At Stake In April is Shocking (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
What’s At Stake In April is Shocking (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What’s At Stake In April is Shocking (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
What’s At Stake In April is Shocking (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
What’s At Stake In April is Shocking (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
What’s At Stake In April is Shocking (Ad)pixel
Intensity and insults rise as lawmakers debate debt ceiling
UK travelers face hours-long waits for ferries to France
What’s At Stake In April is Shocking (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
What’s At Stake In April is Shocking (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
NYSE:AVNS

Avanos Medical - AVNS Earnings Date, Estimates & Call Transcripts

$29.74
+1.00 (+3.48%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$28.91
▼
$29.80
50-Day Range
$27.22
▼
$31.75
52-Week Range
$19.32
▼
$34.83
Volume
311,558 shs
Average Volume
323,142 shs
Market Capitalization
$1.39 billion
P/E Ratio
28.32
Dividend Yield
N/A
Price Target
$30.00

Earnings Summary

Upcoming
Earnings Date
May. 3Estimated
Actual EPS
(Feb. 21)
$0.60 Beat By $0.12
Consensus EPS
(Feb. 21)
$0.48
Last Year's Q1 EPS
(2/23/2022)
$0.46
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

AVNS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVNS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avanos Medical Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.27$0.27$0.27 
Q2 20232$0.35$0.37$0.36 
Q3 20232$0.40$0.46$0.43 
Q4 20232$0.57$0.63$0.60 
FY 20238$1.59$1.73$1.66 
Q1 20241$0.34$0.34$0.34 
Q2 20241$0.42$0.42$0.42 
Q3 20241$0.47$0.47$0.47 
Q4 20241$0.61$0.61$0.61 
FY 20244$1.84$1.84 $1.84

AVNS Earnings Date and Information

Avanos Medical last released its quarterly earnings data on February 21st, 2023. The reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.12. The company had revenue of $217.50 million for the quarter, compared to the consensus estimate of $217.30 million. Its quarterly revenue was up 12.5% on a year-over-year basis. Avanos Medical has generated $1.05 earnings per share over the last year ($1.05 diluted earnings per share) and currently has a price-to-earnings ratio of 28.3. Earnings for Avanos Medical are expected to grow by 19.05% in the coming year, from $1.68 to $2.00 per share. Avanos Medical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 3rd, 2023 based off prior year's report dates.

Avanos Medical Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/3/2023
(Estimated)		        
2/21/2023Q4 2022$0.48$0.60+$0.12$0.84$217.30 million$217.50 million      
11/2/2022Q3 2022$0.35$0.38+$0.03$0.43$205.47 million$202.00 million    
8/9/2022Q2 2022$0.39$0.41+$0.02$0.58$208.28 million$203.00 million    
5/4/2022Q1 2022$0.24$0.26+$0.02$0.40$197.80 million$197.40 million      
2/23/2022Q4 2021$0.40$0.46+$0.06$0.71$191.33 million$193.40 million    
11/2/20219/30/2021$0.27$0.25($0.02)$1.23$183.90 million$184.10 million    
8/2/20216/30/2021$0.23$0.21($0.02)($0.36)$180.56 million$186.40 million    
5/6/20213/31/2021$0.18$0.23+$0.05$0.62$175.68 million$181.00 million  
2/17/2021Q4 2020$0.22$0.28+$0.06$1.55$183.77 million$185.00 million  
11/3/20209/30/2020$0.10$0.21+$0.11$0.02$165.87 million$186.00 million  
8/4/20206/30/2020($0.10)$0.13+$0.23$0.32$147.90 million$163.70 million  
5/6/20203/31/2020$0.16$0.16$0.24$175.15 million$180.40 million  
2/25/2020Q4 2019$0.32$0.34+$0.02$0.81$178.58 million$189.80 million  
11/5/2019Q3$0.32$0.30($0.02)$0.84$179.98 million$171.40 million  
8/6/2019Q2 2019$0.25$0.28+$0.03$0.73$172.02 million$172.20 million  
5/7/20193/31/2019$0.17$0.15($0.02)$0.73$163.72 million$164.20 million  
2/26/2019Q4 2018$0.24$0.33+$0.09$0.71$166.88 million$169.90 million  
11/6/20189/30/2018$0.28$0.37+$0.09$0.65$166.57 million$165.10 million  
8/7/2018Q2 2018$0.38$0.48+$0.10$0.23$157.37 million$160.90 million
5/2/2018Q1 2018$0.55$0.76+$0.21$1.09$153.20 million$156.40 million
2/27/2018Q4 2017$0.49$0.73+$0.24$0.77$417.93 million$166.30 million
11/1/2017Q3 2017$0.45$0.60+$0.15$0.85$396.19 million$401.40 million
8/2/2017Q2 2017$0.38$0.51+$0.13$0.66$400.37 million$399.20 million
5/2/2017Q1 2017$0.43$0.48+$0.05$0.69$391.86 million$395.60 million
2/27/2017Q4 2016$0.45$0.50+$0.05$0.79$401.78 million$410.00 million
11/2/2016Q3 2016$0.40$0.48+$0.08$0.77$387.30 million$397.50 million
8/3/2016Q2 2016$0.36$0.45+$0.09$0.76$382.36 million$400.00 million
5/4/2016Q1 2016$0.34$0.53+$0.19$0.76$370.16 million$384.80 million
2/29/2016Q4 2015$0.50$0.57+$0.07$0.83$402.46 million$401.40 million
11/3/2015Q3 2015$0.48$0.52+$0.04$11.14$386.01 million$389.50 million
8/4/2015Q2 2015$0.54$0.52($0.02)$0.87$405.00 million$389.30 million
5/4/2015Q1 2015$0.64$0.51($0.13)$0.56$394.20 million
3/4/2015Q4 2014$0.75$1.59+$0.84$3.23$439.40 million












Avanos Medical Earnings - Frequently Asked Questions

When is Avanos Medical's earnings date?

Avanos Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 3rd, 2023 based off last year's report dates. Learn more on AVNS's earnings history.

Did Avanos Medical beat their earnings estimates last quarter?

In the previous quarter, Avanos Medical (NYSE:AVNS) reported $0.60 earnings per share (EPS) to beat the analysts' consensus estimate of $0.48 by $0.12. Learn more on analysts' earnings estimate vs. AVNS's actual earnings.

How can I listen to Avanos Medical's earnings conference call?

The conference call for Avanos Medical's latest earnings report can be listened to online. Listen to Conference Call

How can I read Avanos Medical's conference call transcript?

The conference call transcript for Avanos Medical's latest earnings report can be read online. Read Transcript

How can I view Avanos Medical's earnings report?

Avanos Medical's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Avanos Medical generate each year?

Avanos Medical (NYSE:AVNS) has a recorded annual revenue of $820 million.

How much profit does Avanos Medical generate each year?

Avanos Medical (NYSE:AVNS) has a recorded net income of $50.50 million. AVNS has generated $1.05 earnings per share over the last four quarters.

What is Avanos Medical's price-to-earnings ratio?

Avanos Medical (NYSE:AVNS) has a trailing price-to-earnings ratio of 28.32 and a forward price-to-earnings ratio of 17.70.

What is Avanos Medical's EPS forecast for next year?

Avanos Medical's earnings are expected to grow from $1.68 per share to $2.00 per share in the next year, which is a 19.05% increase.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NYSE:AVNS) was last updated on 4/1/2023 by MarketBeat.com Staff